131 related articles for article (PubMed ID: 2133273)
21. Inhibition of estradiol uptake and transforming growth factor alpha secretion in human breast cancer cell line MCF-7 by an alkyl-lysophospholipid.
Kosano H; Yasutomo Y; Kugai N; Nagata N; Inagaki H; Tanaka S; Takatani O
Cancer Res; 1990 Jun; 50(11):3172-5. PubMed ID: 2334912
[TBL] [Abstract][Full Text] [Related]
22. New tumoricidal semisynthetic ether phospholipid, plasmanyl-(N-acyl)ethanolamine (PNAE(s)) and enhancement of its tumoricidal activity by calcium ions.
Kára J; Konovalova AL; Krasnova MA; Liebl V; Bejsovcová L
Neoplasma; 1993; 40(4):213-7. PubMed ID: 8272147
[TBL] [Abstract][Full Text] [Related]
23. Tumor cell kinetics following long-term treatment with antineoplastic ether phospholipids.
Principe P; Sidoti C; Coulomb H; Broquet C; Braquet P
Cancer Detect Prev; 1994; 18(5):393-400. PubMed ID: 7812986
[TBL] [Abstract][Full Text] [Related]
24. Disturbance of phospholipid metabolism during the selective destruction of tumor cells induced by alkyl-lysophospholipids.
Modolell M; Andreesen R; Pahlke W; Brugger U; Munder PG
Cancer Res; 1979 Nov; 39(11):4681-6. PubMed ID: 498095
[TBL] [Abstract][Full Text] [Related]
25. Structure-activity relationships of antineoplastic ring-substituted ether phospholipid derivatives.
Papazafiri P; Avlonitis N; Angelou P; Calogeropoulou T; Koufaki M; Scoulica E; Fragiadaki I
Cancer Chemother Pharmacol; 2005 Sep; 56(3):261-70. PubMed ID: 15856232
[TBL] [Abstract][Full Text] [Related]
26. In vitro antiproliferative activity of combinations of ether lipid analogues and DNA-interactive agents against human tumor cells.
Noseda A; Berens ME; White JG; Modest EJ
Cancer Res; 1988 Apr; 48(7):1788-91. PubMed ID: 3349458
[TBL] [Abstract][Full Text] [Related]
27. The antitumor ether lipid 1-Q-octadecyl-2-O-methyl-rac-glycerophosphocholine (ET-18-OCH3) inhibits the association between Ras and Raf-1.
Samadder P; Richards C; Bittman R; Bhullar RP; Arthur G
Anticancer Res; 2003; 23(3B):2291-5. PubMed ID: 12894505
[TBL] [Abstract][Full Text] [Related]
28. 2-Substituted aminopyrido[2,3-d]pyrimidin-7(8H)-ones. structure-activity relationships against selected tyrosine kinases and in vitro and in vivo anticancer activity.
Klutchko SR; Hamby JM; Boschelli DH; Wu Z; Kraker AJ; Amar AM; Hartl BG; Shen C; Klohs WD; Steinkampf RW; Driscoll DL; Nelson JM; Elliott WL; Roberts BJ; Stoner CL; Vincent PW; Dykes DJ; Panek RL; Lu GH; Major TC; Dahring TK; Hallak H; Bradford LA; Showalter HD; Doherty AM
J Med Chem; 1998 Aug; 41(17):3276-92. PubMed ID: 9703473
[TBL] [Abstract][Full Text] [Related]
29. Increase of transferrin binding induced by an alkyl-lysophospholipid in breast cancer cells.
Kosano H; Takatani O
J Lipid Mediat; 1990; 2(2):117-21. PubMed ID: 2135668
[TBL] [Abstract][Full Text] [Related]
30. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
Showalter HD; Sercel AD; Leja BM; Wolfangel CD; Ambroso LA; Elliott WL; Fry DW; Kraker AJ; Howard CT; Lu GH; Moore CW; Nelson JM; Roberts BJ; Vincent PW; Denny WA; Thompson AM
J Med Chem; 1997 Feb; 40(4):413-26. PubMed ID: 9046331
[TBL] [Abstract][Full Text] [Related]
31. Antiinvasive effect of racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine on MO4 mouse fibrosarcoma cells in vitro.
Storme GA; Berdel WE; van Blitterswijk WJ; Bruyneel EA; De Bruyne GK; Mareel MM
Cancer Res; 1985 Jan; 45(1):351-7. PubMed ID: 4038380
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic effects of alkylphosphocholines or alkylphosphocholine-liposomes and macrophages on tumor cells.
Zeisig R; Jungmann S; Fichtner I; Daemen T; Arndt D
Anticancer Res; 1994; 14(5A):1785-9. PubMed ID: 7847811
[TBL] [Abstract][Full Text] [Related]
33. Inhibition by an alkyl-lysophospholipid of the uptake of epidermal growth factor in human breast cancer cell lines in relation to epidermal growth factor internalization.
Kosano H; Takatani O
Cancer Res; 1989 Jun; 49(11):2868-70. PubMed ID: 2785846
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and structure-activity relationship effects on the tumor avidity of radioiodinated phospholipid ether analogues.
Pinchuk AN; Rampy MA; Longino MA; Skinner RW; Gross MD; Weichert JP; Counsell RE
J Med Chem; 2006 Apr; 49(7):2155-65. PubMed ID: 16570911
[TBL] [Abstract][Full Text] [Related]
35. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
Tomazic VJ; Farha M; Loftus A; Elias EG
J Immunol; 1988 Jun; 140(11):4056-61. PubMed ID: 3372997
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological activities of spirogermanium and other structurally related azaspiranes: effects on tumor cell and macrophage functions.
Mirabelli CK; Badger AM; Sung CP; Hillegass L; Sung CM; Johnson RK; Picker D; Schwartz D; Dorman J; Martellucci S
Anticancer Drug Des; 1989 Mar; 3(4):231-42. PubMed ID: 2930625
[TBL] [Abstract][Full Text] [Related]
37. Cell kill and cytostasis by ET-18-OCH3 and heat.
Fujiwara K; Modest EJ; Wallen CA
Anticancer Res; 1995; 15(4):1333-8. PubMed ID: 7654017
[TBL] [Abstract][Full Text] [Related]
38. Effect of alkyl-lysophospholipid analogs on the morphology of a murine lymphoma cell line.
Vagnetti D; Mancini A; Santarella B; Binaglia L
J Submicrosc Cytol Pathol; 1990 Jul; 22(3):415-24. PubMed ID: 2390764
[TBL] [Abstract][Full Text] [Related]
39. Platelet aggregating material (PAM) of two virally-transformed tumors: SV3T3 mouse fibroblast and PW20 rat renal sarcoma. Role of cell surface sialylation.
Karpatkin S; Pearlstein E; Salk PL; Yogeeswaran G
Prog Clin Biol Res; 1982; 89():445-77. PubMed ID: 7111309
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of 1-O-alkyl-2-O-methyl-glycerophospholipids with potential antitumor activity.
Alunni-Bistocchi G; Orvietani PL; Ricci A; Binaglia L; Orlando M; Orlando P
Farmaco; 1990 May; 45(5):499-509. PubMed ID: 2222722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]